Nutrients (Feb 2024)

Correlation between Selenium and Zinc Levels and Survival among Prostate Cancer Patients

  • Sandra Pietrzak,
  • Wojciech Marciniak,
  • Róża Derkacz,
  • Milena Matuszczak,
  • Adam Kiljańczyk,
  • Piotr Baszuk,
  • Marta Bryśkiewicz,
  • Andrzej Sikorski,
  • Jacek Gronwald,
  • Marcin Słojewski,
  • Cezary Cybulski,
  • Adam Gołąb,
  • Tomasz Huzarski,
  • Tadeusz Dębniak,
  • Marcin R. Lener,
  • Anna Jakubowska,
  • Tomasz Kluz,
  • Rodney J. Scott,
  • Jan Lubiński

DOI
https://doi.org/10.3390/nu16040527
Journal volume & issue
Vol. 16, no. 4
p. 527

Abstract

Read online

The most prevalent type of cancer among males is prostate cancer. Survival is considered quite good, but it can be further improved when risk factors are optimized. One of these factors is micronutrients, including Se and Zn. To our knowledge, the interaction between Se and Zn and prostate cancer remains undescribed. This study aimed to investigate the optimal levels of selenium (Se) and zinc (Zn) and their impact on the survival of individuals diagnosed with prostate cancer. A total of 338 prostate cancer patients were enrolled in this study, which was conducted in Poland between 2009 and 2015. Mass spectrometry, which uses inductively coupled plasma mass, was used to assess serum element levels before treatment. The study participants were categorized into quartiles (QI-QIV) based on the distributions of Se and Zn levels observed among surviving participants. Cox regression was used to assess the association between serum Se and Zn levels and the survival of prostate cancer patients. Our results reveal the effect of combined Se and Zn levels on survival in prostate cancer patients (SeQI-ZnQI vs. SeQIV-ZnQIV; HR = 20.9). These results need further research to establish Se/Zn norms for different populations.

Keywords